Few French medical schools have formally adopted any conflict of interest policies, a new analysis finds, despite a law requiring faculty members to disclose financial ties and a scandal a decade ago that cast a harsh spotlight on the influence of drug makers on prescribing practices and regulators.

None of the 37 medical schools examined had official policies governing conflicts, and just two had what were described as informal polices, since these were not available in writing or on school websites, according to the analysis, which was published earlier this month PLOS One. Nine schools, meanwhile, offered related courses or policies, but were not well-defined.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!


What is it?

STAT Plus is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • Online intelligence briefings
  • Frequent opportunities to engage with veteran beat reporters and industry experts
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy